acyclovir
Generic: acyclovir
Labeler: hikma pharmaceuticals usa inc.Drug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
hikma pharmaceuticals usa inc.
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
acyclovir sodium 1 g/1
Manufacturer
Identifiers & Regulatory
Product NDC
0143-9658
Product ID
0143-9658_dbf69540-34d6-423d-a06a-e5eddfd40ae3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA205771
Listing Expiration
2026-12-31
Marketing Start
2016-02-29
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
01439658
Hyphenated Format
0143-9658
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA205771 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1 g/1
Packaging
- 10 VIAL, SINGLE-DOSE in 1 BOX (0143-9658-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0143-9658-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "dbf69540-34d6-423d-a06a-e5eddfd40ae3", "openfda": {"unii": ["927L42J563"], "rxcui": ["2263503", "2263505"], "spl_set_id": ["babdbce2-5cbd-4943-bc38-9ebdd696a77a"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 BOX (0143-9658-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0143-9658-01)", "package_ndc": "0143-9658-10", "marketing_start_date": "20160229"}], "brand_name": "Acyclovir", "product_id": "0143-9658_dbf69540-34d6-423d-a06a-e5eddfd40ae3", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "0143-9658", "generic_name": "Acyclovir", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR SODIUM", "strength": "1 g/1"}], "application_number": "ANDA205771", "marketing_category": "ANDA", "marketing_start_date": "20160229", "listing_expiration_date": "20261231"}